CClinicalTrials.gg
CompletedNCT02540681ProFitUpdated Mar 24, 2021

Prosthetic Fit Assessment in Transtibial Amputees Secondary to Trauma

An observational study in Traumatic Amputation of Lower Extremity, sponsored by Major Extremity Trauma Research Consortium. Completed at 10 sites in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2021-03-24.

Sponsored by Major Extremity Trauma Research Consortium · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
33
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The aims of this study address an exploratory endpoint in the Major Extremity Trauma Research Consortium (METRC) Transtibial Amputation Outcomes Study (TAOS; NCT01821976) that is investigating prosthesis fit, alignment and condition of the residual limb. As there are no validated measures of fit and alignment (factors known to impact comfort, function and performance among amputees) the TAOS study includes a provision in the protocol for acquisition of photographs, video and radiographs in order to help develop uniform assessments of the residual limb. The goal of the ProFit study is to validate and refine the prosthetic assessment tool (ProFit) that was developed by an expert panel of certified orthotist prosthetistis (CPOs) in collaboration with orthopaedic trauma investigators, a measurement scientist and a biomedical engineer from the BADER consortium.

Read the detailed description

Specific Aim 1: To test the reliability of the ProFit.

Patients enrolled in the TAOS trial returning for their eighteen month final visit will undergo radiographic, video, and photographic assessment. A blinded prosthetist panel (PP) will view these remotely and complete a 42 item assessment based on x-ray, photo and video. We will examine two aspects of reliability for the ProFit, inter-rater reliability and internal consistency.

Specific Aim 2: To examine the validity and responsiveness of the ProFit.

This study aims to examine the validity of the ProFit by specifically evaluating factor validity, construct validity and discriminant validity. This will be accomplished by correlating ProFit scores with measures of self-reported pain (Brief Pain Inventory), function (Short Musculoskeletal Functional Assessment), and satisfaction (Orthotics and Prosthetics User's Survey). Moreover, a subset of subjects will undergo quantitative measurement of fit and alignment using a novel prosthesis-mounted socket reaction moment sensor. Responsiveness of the ProFit will be based on repeated measurements at 6 and 18 months.

Specific Aim 3: To develop a shorter version of the ProFit.

Based on findings from Aim 1 and 2 at the individual item level, we will remove items that: 1) have poor inter-rater agreement; 2) demonstrate weak relationships with clinician and patient report of overall fit; or 3) exhibit strong ceiling or floor effects.

Study design: The ProFit study is a prospective validation study of an assessment of prosthetic fit and alignment among patients with a transtibial amputation.

Study duration: 3 years Sample size: 120 TAOS patients will provide adequate power to detect important differences in fit and alignment 18 months following amputation. A subset of 60 patients is necessary to detect significant differences in alignment using the Smart Pyramid.

Number of study sites: Up to 35 centers including 24 Core METRC sites, 4 MTFs, and 7 METRC satellite sites.

Study population: Patients enrolled in the METRC TAOS study.

Outcome measure: This ancillary project to the TAOS trial is designed to study the validity reliability and validity of the ProFit, a 42-item tool for assessing prosthetic fit and alignment among patients with a transtibial amputation.

Statistical analysis: Inter-rater reliability and internal consistency will be examined to test the reliability of the ProFit. The validity of this assessment will be evaluated using a variety of construct validity tests. Based on findings from the reliability and validity analysis, a shorter version of the ProFit will be developed. The performance of the shorter version will be determined based on correlation with the original assessment.

Randomization: Not applicable

Safety monitoring: Not applicable

02

Conditions studied

  • Traumatic Amputation of Lower Extremity

Browse trials for

Keywords

  • Transtibial amputation
  • Prosthetic fit
  • Prosthetic alignment
03

In context

Amputation, Traumatic

101 studies on the registry are indexed under Amputation, Traumatic; 14 are open to participants now.

This study's enrollment of 33 is close to the median of 34 across 30 observational studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Major Extremity Trauma Research Consortium is the lead sponsor of 32 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be drawn from the TAOS study which enrolls patients with below the knee amputations from trauma centers participating in the Major Extremity Research Consortium (METRC).

Inclusion criteria

  • Must be enrolled in the TAOS study

Exclusion criteria

Exclusion Criteria:

  • Patients weighing \<300 lbs.
  • Patient requires an LAR
  • Women who are breastfeeding or pregnant
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
33 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prosthetic Fit and Alignment

    A panel of CPOs will evaluate prosthetic fit and alignment using a 42 item assessment tool.

    Time frame: 18 months

Secondary outcomes

  1. Reliability of ProFit assessment tool

    Time frame: 18 months

  2. Validity of ProFit Assessment tool

    Time frame: 18 months

  3. Responsiveness of ProFit Assessment tool

    Time frame: 18 months

07

Study locations

10 sites
  • University of California at San Francisco
    San Francisco, California 94110, United States
  • Tampa General Hospital
    Tampa, Florida 33606, United States
  • University of Maryland, R Adams Cowley Shock Trauma Center
    Baltimore, Maryland 20742, United States
  • University of Mississippi Medical Center
    Jackson, Mississippi 39216, United States
  • Carolinas Medical Center
    Charlotte, North Carolina 28204, United States
  • Wake Forest University Baptist Center
    Winston-Salem, North Carolina 27157, United States
  • MetroHealth Medical Center
    Cleveland, Ohio 44109, United States
  • Vanderbilt University
    Nashville, Tennessee 37232, United States
  • The University of Texas Health Science Center at Houston Medical School
    Houston, Texas 78229, United States
  • San Antonio Military Medical Center
    San Antonio, Texas 78234, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02540681
Lead sponsor
Major Extremity Trauma Research Consortium
Collaborators
University of California, San Francisco
Responsible party
Sponsor
First posted
Sep 4, 2015
Start date
Jan 2015
Primary completion
Jan 2021
Completion
Jan 2021
Last update
Mar 24, 2021

Study contacts

Lisa Reider, PhD
study director · Major Extremity Trauma Research Consortium

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion